Radius Health (RDUS) Moves to Session Highs as Rumors Continue
- Stocks close with gains, led by Dow as investors look for rate insight
- Piper Sandler: Stock rally likely to continue on rising recession risks
- Robinhood (HOOD) rises after saying it plans to launch a credit card for US consumers
- Short sellers target Reddit shares as stock slips
- RH touts 'exceptional' demand for new collections after Q4 results fall short
- Discover Financial Services (DFS) Announces CEO Resignation
- Timken (TKR) Appoints Tarak Mehta as New CEO
- Crude Inventory Increases 3.2 Million Barrels
- Intuitive Machines (LUNR) Files for $300M Share Offering, 160M Share Offering by Selling Stockholders
- Fisker (FSR) Cuts US Prices of Ocean SUV Up to 39% - Bloomberg
Jefferies Boosts PT on Radius Health (RDUS) to $46 Amid Solid Physician Poll Data
August 15, 2016 8:43 AM EDTJefferies boosts its price target on Hold-rated Radius Health (Nasdaq: RDUS) from $37 to $46 today following recent physician poll results.
Analyst Eun Yang commented, Our physician poll shows convenient abalo-TD patch for osteoporosis, if successful, would increase abalo use by ~25-30% (vs. injectable abalo-SC). Given abalo-TD patch late-breaker presentation on 9/19/16 and likely positive... More
Radius Health (RDUS) Sees Early Gains on Continued Takeover Chatter
August 12, 2016 9:18 AM EDTRadius Health (NASDAQ: RDUS) is up 2% in pre-open trade following another report from the Telegraph that the company is a target of takeover bids.
SI NOTE: This stock has been subject of renewed rumors over the past three sessions and in... More
Takeover Rumors Continue to Swirl Around Radius Health (RDUS)
August 11, 2016 9:38 AM EDTRadius Health (NASDAQ: RDUS) is on watch amid continued takeover speculation. The FT reported rumors the company rejected a $70/share bid from Shire (NASDAQ: SHPG) and Shire is weighing raising its bid to $80. Shares of RDUS last traded up 1.1% to $52.55.
... MoreRadius Health (RDUS) on Watch Amid Renewed Takeover Rumors
August 10, 2016 9:27 AM EDTRadius Health (NASDAQ: RDUS) on watch amid renewed rumors the company is the target of a takeover bid.